Puma Biotechnology
PBYI
199 hedge funds and large institutions have $6.87B invested in Puma Biotechnology in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 86 increasing their positions, 56 reducing their positions, and 20 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 56
50% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 20
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
34% more capital invested
Capital invested by funds: $5.14B → $6.87B (+$1.73B)
5% more funds holding
Funds holding: 189 → 199 (+10)
1.18% more ownership
Funds ownership: 90.06% → 91.23% (+1.2%)
13% less call options, than puts
Call options by funds: $56.3M | Put options by funds: $64.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$127M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$81.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$49.5M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$35.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$32.2M |
| 2 |
FAM
Fred Alger Management
New York
|
-$24.1M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$17.8M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$14.9M |
| 5 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
-$12M |
PBYI Hedge Fund Activity: Q1 2015 in Review
199 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q1 2015, worth a combined $6.87B — up 34% from $5.14B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new PBYI positions and 20 closed out — a net gain of 10 holders — while 86 added to existing stakes and 56 trimmed.
The largest buyer was Franklin Resources, adding an estimated $127M. The largest seller was Wells Fargo, cutting an estimated $32.2M.
- 199 institutional investors held Puma Biotechnology (PBYI) as of Q1 2015, up from 189 in Q4 2014.
- Funds reported $6.87B of Puma Biotechnology stock for Q1 2015, up 34% quarter-over-quarter.
- 30 funds opened new Puma Biotechnology positions in Q1 2015 and 20 closed out, a net change of +10 holders.
- The largest Puma Biotechnology buyer in Q1 2015 was Franklin Resources, an estimated $127M added.
- The largest Puma Biotechnology seller in Q1 2015 was Wells Fargo, an estimated $32.2M sold.
Based on aggregated 13F filings for Q1 2015.